Skip to content

Clinical trials

Phase 2 Parkinsonian Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinsonian Disorders Phase: Phase 2 Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20041
20062
20081
20111
20122
20232
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting2
Terminated2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute for Neurodegenerative Disorders5
Novartis Pharmaceuticals3
Akiva Mintz1
Bial R&D Investments, S.A.1
GE Healthcare1
National Institute of Neurological Disorders and Stroke (NINDS)1
Neurologix, Inc.1
University of Pennsylvania1
Vima Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinsonian Disorders15
Parkinson Disease10
Movement Disorders7
Disease4
Neurodegenerative Diseases4
Central Nervous System Diseases3
Dyskinesias3
Basal Ganglia Diseases2
Brain Diseases2
Nervous System Diseases2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.